$JAGX
Jaguar Health, Inc.
XNAS
Why is JAGX up today? It is at $0.917 (+5.71%), and our scanner flagged it 7 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment JAGX spikes, and full due diligence on JAGX — key stats, earnings, dilution and insider activity. Free.
Get free $JAGX alerts the moment volume spikes
Our scanner flagged $JAGX 7 times in the last 30 days. Create a free account to track $JAGX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $0.917
- Change today
- +5.71%
- Previous close
- $0.868
- 52-week range
- $0.725 – $77.63
- Market cap
- $4M
- Institutional own.
- 0.10%
- Total held
- 0.28%
- Tradeable float
- 4.9M 100% of shares · after <1% insiders + 0% institutions
- Short interest
- 87K ▲ +69% vs prior · as of 2026-07-31
- Short % of float
- 1.8%
- Days to cover
- 1.0d
- Avg daily volume
- 73K
- Exchange
- XNAS
- 5mthin
- 0.2x
- 15mthin
- 0.2x
- 1hthin
- 1.7x
- 1D
- 1.5x
Get free JAGX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $JAGX up today?
Here is the latest on JAGX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for JAGX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystJaguar Health Reports Second Quarter 2026 FinancialsReported weight of up to 48% in patient with the ultrarare microvillus inclusion disease (MVID); company expects clinical package for NDA for MVID to be ready by end of 2026, allowing submission of NDA in Q2 2027Reported Mytesi® and Canalevia®-CA1 products. License revenues for the initial $16 million upfront payment, in addition to theReported $3 million payment for early termination of the Buy-Back Option under this agreement, were recognized by the Company in the first quarter of 2026. As announced in August 2026, Jaguar has satisfied the, from an SEC filing. Read it →Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $JAGX. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$JAGX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$JAGX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
JAGX stock FAQ
Why is $JAGX up today?
Here is the latest on JAGX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for JAGX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the JAGX stock price today?
JAGX last traded at $0.917, up 5.71% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live JAGX alerts?
The JAGX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged JAGX 7 times in the last 30 days.
What exchange is JAGX on?
JAGX (Jaguar Health, Inc.) trades on XNAS, with a market cap of about $4M.
Is JAGX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge JAGX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.